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Shiga toxin 2 (Stx2) has been reported as the main Shiga toxin associated with human disease. In addition,
the Stx2 toxin type can have a profound impact on the degree of tissue damage in animal models. We have
characterized the stx2 subtype of 168 Shiga toxin-producing Escherichia coli (STEC) isolates of which 146 were
derived from ovine sources (principally feces and meat) and 22 were isolated from humans. The ovine STEC
isolates were of serotypes that have been shown to occur commonly in the gastrointestinal tract of healthy
sheep. The major stx2 subtype in the ovine isolates was shown to be stx2d-Ount (119 of 146 [81.5%]) and was
predominantly associated with serotypes O75:H2/H8/H40, O91:H2, O123:H2, O128:H2, and OR:H2. However,
17 of 18 (94.4%) ovine isolates of serotype O5:H2 possessed a stx2d-O111/OX3a subtype. Furthermore, STEC
isolates of serotypes commonly found in sheep and recovered from both clinical and nonclinical human
infections also contained a stx2d (stx2d-Ount/O111/OX3a) subtype. These studies suggest that a specific stx2
subtype(s) associates with serotype and may have important epidemiological implications for tracing sources
of E. coli during outbreaks of STEC-associated diseases in humans.
Multiple virulence factors contribute to the pathogenicity of
Shiga toxin-producing Escherichia coli (STEC). Although
Shiga toxins are the primary virulence factor, the ability to
produce intimin (encoded by eaeA) and the possession of a
plasmid encoding enterohemolysin (ehxA) are also important
(2, 5, 11, 14). Shiga toxins comprise two immunologically non-
cross-reactive groups designated Shiga toxin 1 (Stx1) and Shiga
toxin 2 (Stx2). Stx1 is virtually identical to the Shiga toxin of
Shigella dysenteriae (21). Stx2 is considered to be the most
important virulence factor associated with human disease (5,
22). In addition, Stx2 is about 400-fold more toxic to mice than
Stx1 and has also been shown to induce fetoplacental resorp-
tion, intrauterine hematoma, fibrin deposition, and neutrophil
infiltration when injected intravenously into mice on day 5 of
pregnancy (32, 34). Unlike for stx1, considerable sequence vari-
ation among stx2 genes has been reported (12, 26, 30, 33).
More importantly, differences in the degree of pathogenicity of
STEC serotypes have been associated with variations in the stx2
subtype (13, 16, 17).
At least 10 stx2 gene variants have been described (10, 12, 19,
24, 25, 26, 29, 30, 33). The most prevalent Stx2 variants are
stx2c, stx2d, and stx2e (26, 30, 33). stxc was isolated from E. coli
O157:H2 strain E32511 and is closely related to stx2 and stx2vha
(30). The stx2d cluster as defined by Pierard et al. (26) com-
prises stx2d-O111 (24), stx2d-OX3a (25), and stx2d-Ount variants,
and these subtypes were identified in non-O157 STEC strains
isolated from humans and meat (26, 27). However, stx2d-pos-
itive STEC strains are not observed in the most virulent sero-
groups for humans, including O157, O26, O103, O111, and
O145 and have been reported to be less frequently associated
with diarrhea and hemolytic uremic syndrome (HUS) (26).
stx2e is predominantly associated with edema disease in swine
(33) and is rarely recovered from humans.
The importance of characterizing Stx2 types has been re-
cently highlighted by the observation that mouse or human
colonic mucin (18) can activate some Stx2 toxins. The Vero cell
cytotoxicity of intestinal mucus-treated Stx2vha/b was reported
to increase 35- to 350-fold compared to non-mucin-treated
Stx2vha/b. Mucin activation provides an explanation for the
observation that STEC strains expressing Stx2vh are highly
virulent (50% lethal dose of ,10 CFU) when fed to strepto-
mycin-treated CD-1 mice compared to STEC strains express-
ing Stx2c (50% lethal dose of 1010 CFU) (16, 17).
Recent studies of sheep in eastern Australia have demon-
strated that the predominant STEC serotypes containing ac-
cessory virulence factors (enterohemolysin and/or intimin) are
O5:H2, O75:H8, O91:H2, O123:H2, and O128:H2 (6a), and
several of these serotypes have been occasionally isolated from
clinically affected patients. More than 60 different serotypes of
STEC have been isolated from humans with clinical infections
(1). Many STEC isolates of ovine origin contain stx2 and ex-
press toxin (6a). However, only a few reports have examined
stx2 subtypes among STEC isolates recovered from ruminant
sources, particularly sheep. The aims of this study were (i) to
determine the stx2 subtype(s) of STEC isolates derived from
ovine sources and (ii) to determine the stx2 subtypes among
human STEC isolates that possess a serotype commonly asso-
ciated with sheep, with the purpose of determining if sheep
represent a source of STEC for human infections.
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MATERIALS AND METHODS
STEC isolates. One hundred sixty-eight STEC isolates were used in this study
(Table 1). The Elizabeth Macarthur Agricultural Institute (New South Wales,
Australia) provided 124 isolates, which were isolated using methods described by
Djordjevic et al. (6a). Of these, 121 were isolated from healthy sheep and 3 were
isolated from diagnostic submissions in which STEC was not necessarily impli-
cated as the cause of the disease. Thirty-four isolates were obtained from the
Victorian Infectious Diseases Laboratory (Melbourne, Australia). These con-
sisted of 11 isolates of human origin, 9 isolates from lamb meat, 2 isolates from
sheep feces, 1 isolate from a meat sausage, and 10 isolates from lamb carcasses.
Andre Burnens from the National Reference Laboratory for Foodborne Dis-
eases (Bern, Switzerland) provided 10 human isolates from patients with diar-
rhea or HUS (6, 7). The Swiss isolates possessed serotypes not commonly found
in STEC isolates recovered from ovine sources and were included in this study
for comparative purposes only. The Swiss isolates were serotyped by Kim Ziebel
and Roger Johnson from the Guelph Laboratory, Health Canada, Guelph, On-
tario, Canada.
Multiplex PCR analysis of STEC isolates. All isolates were prepared and
subjected to multiplex PCR for the detection of STEC virulence factors stx1, stx2,
ehxA, and eaeA as described by Paton and Paton (23), with the following mod-
ification. For DNA preparation, Instagene matrix (Bio-Rad, Richmond, Calif.)
was used as described by Fagan et al. (8). Amplified DNA fragments were
resolved by gel electrophoresis (28) using 2% (wt/vol) agarose. Gels were stained
with ethidium bromide, visualized with UV illumination, and imaged using a
GelDoc 1000 image analysis station (Bio-Rad).
stx2 subtyping. Ovine and human STEC isolates (Table 1) containing stx2 were
subjected to stx2 subtyping as described by Pierard et al. (26) and Bastian et al.
(3). The primer sequences used are listed in Table 2. For this report stx2d
(stx2d-Ount, stx2d-O111, and stx2d-OX3a) is defined as a nucleotide sequence variant
of stx2 as described by Peirard et al. (26) and does not refer to the mucin-
inducible Stx2d toxin subtype (encoded by stx2vha and stx2vhb) as defined by
Melton-Celsa et al. (17).
stx2 amplified with VT2-e and VT2-f primers (Table 2) was subjected to
restriction endonuclease digestion with HaeIII and PvuII as described by Pierard
TABLE 1. Virulence factor profiles and stx2 subtypes of ovine and human STEC isolates
Serotype Sourcea Total no.of isolates
Virulence Profile No. of isolates containing stx2 variant:
stx1 stx2 ehxA eaeA stx2 stx2d-Ount stx2d-OX3a/O111 stx2vha stx2vhb
O5:H2 Sheep feces, NSW (E) 17 1 1 1 2 17
O5:H2 Sheep feces, NSW (E) 1 2 1 1 2 1
O5:H2 Human, Australia, HUS (V) 1 1 1 1 2 1
O8:H14 Human, HUS (S) 1 2 1 2 2 1
O7:H2 Human, HUS (S) 1 2 1 1 1 1
O15:H2b Human, HUS (S) 1 2 1 1 1
O26:H2 Human, HUS (S) 2 2 1 2 1 2
O75:H2 Sheep feces, NSW (E) 1 1 1 1 2 1
O75:H8 Sheep feces, NSW (E) 16 1 1 1 2 16
O75:H40 Sheep feces, NSW (E) 1 1 1 1 2 1
O91:H2 Sheep feces, NSW (E) 36 1 1 1 2 34 2
O91:H2 Human, Australia, Symptomless (V) 1 1 1 2 2 1
O91:H2 Human, Australia, Diarrhea (V) 1 1 1 2 2 1
O91:H2 Lamb carcasses, Queensland (V) 9 1 1 1 2 8 1
O91:H2 Lamb carcasses, Queensland (V) 1 2 1 2 2 1
O91:H2 Lamb meat, New Zealand (V) 6 1 1 1 2 6
O91:H2 Lamb meat, New Zealand (V) 3 1 1 2 2 3
O91:H2 Sheep feces, New Zealand (V) 1 1 1 1 2 1
O91:H2 Sheep feces, USA (V) 1 1 1 1 2 1
O91:H2 Meat sausage, Australia (V) 1 1 1 2 2 1
O91:H2 Sheep feces, NSW (E) 1 1 1 1 2 1
O91:H10 Human, Australia, Diarrhea (V) 1 2 1 2 2 1
O91:H21c Human, New Zealand, Diarrhea (V) 1 2 1 1 2 1 1
O103:H38 Sheep feces, NSW (E) 1 1 1 1 2 1
O121:H19 Human, HUS (S) 1 2 1 1 1 1
O121:H19 Human, Diarrhea (S) 1 2 1 2 1 1
O123:H2 Sheep feces, NSW (E) 22 1 1 1 2 21 1
O123:H2 Sheep feces, Diagnostic, NSW (E) 3 1 1 1 2 3
O123:H2 Human, Australia, Diarrhea (V) 1 1 1 1 2 1
O128:H2 Sheep feces, NSW (E) 12 1 1 1 2 12
O128:H2 Human, Australia, Diarrhea (V) 3 1 1 1 2 3
O128:H2 Human, New Zealand, Diarrhea (V) 1 1 1 1 2 1
O128:H2 Human, Australia, Diarrhea (V) 1 1 1 2 2 1
O128:H2 Human, New Zealand, Diarrhea (V) 1 1 1 2 2 1
O128:H2 Sheep feces, NSW (E) 2 1 1 1 2 2
O145:H2 Human, HUS and diarrhea (S) 2 2 1 2 1 1 1
O153:H2 Sheep feces, NSW (E) 2 1 1 1 2 2
O153:H25 Sheep feces, NSW (E) 1 1 1 1 2 1
O157:H2 Sheep feces, NSW (E) 2 1 1 1 1 2
O157:H2 Sheep feces, NSW (E) 1 2 1 1 1 1
O157:H21 Sheep feces, NSW (E) 1 1 1 1 1 1
OR:H2 Sheep feces, NSW (E) 4 1 1 1 2 4
OX3:H8 Human, HUS (S) 1 1 1 2 2 1
a E, isolates obtained from Elizabeth Macarthur Agricultural Institute, New South Wales, Australia; V, isolates obtained from Victorian Infectious Diseases
Laboratory, Victoria, Australia; S, isolates obtained from National Reference Laboratory for Foodborne Diseases, Bern, Switzerland.
b stx2 untypeable.
c Strain with two different stx2 subtypes.
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et al. (26). The PCR product obtained with the LinF and LinR primers (Table 2)
was digested with HincII and AccI as described by Bastian et al. (3). PCR
products (10 ml) were incubated with 5 U of appropriate enzyme in the buffer
provided by the manufacturer. Restriction fragments were separated by agarose
gel electrophoresis. stx2 subtypes were identified based on their restriction pro-
files (Table 3).
stx2 DNA sequence analysis. An O91:H2 isolate (isolate 122-A1) was chosen
as a source of stx2 for sequencing studies for the following reasons. Firstly,
O91:H2 is the most common ovine STEC serotype recovered from Australian
sheep. Secondly, the stx2d restriction fragment length polymorphism profile in-
dicated that it possessed a stx2d-Ount subtype, which is the most common stx2
subtype observed among STEC isolates from the feces of Australian sheep. The
A and B subunits of stx2 from isolate 122-A1 were amplified using oligonucleo-
tide primers Stx2F and Stx2R (Table 2). PCRs were carried out in a 50-ml total
volume containing 5 ml of nucleic acid (extracted with Instagene matrix) from the
isolate, 10 mM Tris-HCl (pH 8.3), 10 mM KCl, 2 mM MgCl2, 10 pmol of each
primer, 200 mM (each) deoxynucleotide triphosphates, and 1 U of Taq DNA
polymerase. After an initial denaturing step of 5 min at 95°C, the samples were
subjected to 35 cycles of denaturation (95°C, 30 s), annealing (60°C, 45 s), and
extension (72°C, 90 s), followed by a single final extension step of 5 min at 72°C.
PCR products were analyzed by agarose gel electrophoresis and purified using a
QIAquick DNA purification kit (Qiagen, Hilden, Germany). Primers used for
sequencing are listed in Table 2. DNA sequence reactions were performed using
the Big Dye terminator cycle sequencing ready reaction DNA sequencing kit and
electrophoresed on an ABI prism 377 DNA sequencer (Perkin-Elmer, Santa
Clara, Calif.). Compilation and analysis of DNA sequence data were performed
using Auto Assembler software (Perkin-Elmer). Nucleotide and amino acid
homology analysis was performed using the Blast program located on the Aus-
tralian National Genomic Information Service website (http://www.angis.org.au).
Nucleotide sequence accession number. The sequence of stx2 from the ovine
O91:H2 isolate (122-A1) has been submitted to the GenBank database under
the accession no. AF298816.
RESULTS
Detection of STEC virulence factors using multiplex PCR.
All 146 ovine STEC isolates contained stx2. Of these, 143
(97.9%) contained stx1 and stx2, 139 (95.2%) contained stx1,
stx2, and ehxA, and 3 (2%) contained all four virulence factors.
All 22 human STEC isolates contained stx2. Eleven (50%) of
these contained stx1 and stx2, three (13.6%) contained stx2,
ehxA, and eaeA, and none contained all four virulence factors.
The virulence factor profiles for all isolates are presented in
Table 1.
Subtyping of stx2. The most common stx2 subtype observed
among STEC isolates from sheep was stx2d-Ount (Fig. 1; Table
3). Specifically, 55 of 58 (94.8%) O91:H2, 16 of 16 (100%)
O75:H8, 24 of 25 (96%) O123:H2, 12 of 12 (100%) O128:H2,
and 4 of 4 (100%) OR:H2 STEC isolates from sheep contained
stx2d-Ount. Seventeen of 18 (94.4%) O5:H
2, 3 of 58 (5.1%)
O91:H2, and 1 of 25 (4%) O123:H2 STEC isolates from sheep
were found to contain either stx2d-O111 or stx2d-OX3a. These
latter two stx2 variants were not differentiated due to their high
nucleotide sequence homology (99%). Of the 10 human iso-
lates with serotypes commonly isolated from sheep, 9 (90%)
also contained stx2d-Ount. The human O5:H
2 isolate contained
stx2d-O111 and/or stx2d-OX3a. The four ovine O157:H
2/H21 iso-
lates possessed stx2vha. Other human isolates with serotypes not
commonly found in sheep contained either stx2 or stx2vhb vari-
ants (Fig. 2; Table 3). One strain of serotype O91:H21 from a
TABLE 2. Primers used to amplify stx2
Primer Sequence (59 to 39) Product size (bp) Reference
Primers for typing stx2
VT2-e AATACATTATGGGAAAGTAATA 348 26
VT2-f TAAACTGCACTTCAGCAAAT
LinF GAACGAAATAATTTATATGT 900a 15
LinR TTTGATTGTTACAGTCAT
Primers for sequencing stx2
Stx2F TATCTGCGCCGGGTCT 1,280 This study
Stx2R CAAAKCCKGARCCTGA
Paton F GGCACTGTCTGAAACTGCTCC 256 26
Paton R TCGCCAGTTATCTGACATTCTG
Gannon F CCATGACAACGGACAGCAGTT 779 9
Gannon R CCTGTCAACTGAGCACTTTG
a The size of the Lin amplicon varies by a few nucleotides depending on the variant.
TABLE 3. Sizes of restriction fragments used for restriction fragment length polymorphism analysis of stx2
Primers used to
amplify fragment
Restriction
enzyme
Expected fragment size(s) (bp) for:
Reference
stx2 stx2vha stx2vhb stx2d-Ount stx2d-OX3a/O111
VT2-e, VT2-f HaeIII 348 216, 132 216, 132 216, 132 167, 132, 49a 26
PvuII 323, 25a 323, 25a 250, 73, 25a 200, 120, 28a 200, 120, 28a
LinF, LinR HincII 556, 263, 62,a 25a 556, 322, 25a 556, 347 881, 25a 881, 25a 3
AccI 554, 352 551, 352 551, 352 906 554, 352
a Fragment was too small to visualize under the electrophoresis conditions used.
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human source contained stx2 in combination with stx2vhb. The
stx2 variant in the human strain with serotype O15:H
2 was
untypable.
stx2 sequence analysis. DNA sequence analysis of stx2 from
the O91:H2 (122-A1) isolate showed 99% homology with
stx2d-Ount (GenBank accession no. AF043627). The stx2 DNA
sequence was also highly homologous (97%) to stx2d-OX3a (ac-
cession no. X65949) and stx2d-O111 (accession no. L11078).
These stx2 variants are grouped together as stx2d as described
by Pierard et al. (26).
DISCUSSION
Although STEC may contain at least four well-characterized
virulence factors (Stx1, Stx2, intimin, and enterohemolysin),
Stx2 is considered the most important factor affecting human
health (5, 22, 34). In this study the stx2 subtypes of 146 STEC
isolates from sheep and 22 human isolates were determined.
stx2d variants were most predominant among ovine isolates
(141 of 146 [96.6%]). Of these, 119 were stx2d-Ount positive,
which was found in association with serotypes O75:H2/H8/
H40, O91:H2, O123:H2, O128:H2/H2, OR:H2, and O153:
H25/H2. stx2d-O111/OX3a subtypes were found in the remaining
22 ovine isolates, of serotypes O5:H2, O91:H2, O91:H2, and
O123:H2. The four ovine isolates of serotype O157:H2/H21
possessed a stx2vha subtype, and the single ovine O5:H
2 isolate
possessed a stx2 subtype.
Of the 22 human STEC isolates, 10 possessed serotypes
commonly associated with STEC derived from ovine feces
(6a). Nine STEC isolates (six of serotype O128:H2, two of
O91:H2, and one of O123:H2) were recovered from seven
patients with diarrhea and from two asymptomatic carriers
and possessed the stx2d-Ount subtype. Furthermore, isolates
OX3:H8 (Switzerland) and O5:H2 (Australia) were each re-
covered from HUS patients and possessed the stx2d-Ount sub-
type and the stx2d-OX3a and/or stx2d-O111 subtypes, respectively.
The O5:H2 isolate from the HUS patient is genetically indis-
tinguishable from several epidemiologically unrelated O5:H2
isolates recovered from sheep by pulsed-field gel electrophore-
sis (31). Collectively, these observations suggest that this iso-
late had an ovine origin.
Twelve human isolates were of serotypes not commonly
associated with sheep (O7:H2, O8:H14, O15:H2, O26:H2,
O91:H10, O91:H21, O121:H19, O145:H2, and OX3:H8).
These were recovered from patients with symptoms ranging
from diarrhea to HUS and also included an isolate from a
symptomless carrier. All of these isolates possessed stx2 and
stx2vhb subtypes, and one isolate (O91:H21) contained two sub-
types of stx2 and stx2vhb. However, it is important to emphasize
that none of the human isolates from Switzerland possessed a
serotype representative of the vast majority of isolates recov-
ered from ovine sources. These data are consistent with studies
by Pierard et al. (26) showing that STEC strains normally
associated with human disease (serogroups O157, O111, O26,
O103, and O145) do not possess a stx2d subtype and that
stx2d-positive isolates are less frequently associated with HUS.
These and previous studies reinforce the hypothesis that cer-
FIG. 1. HaeIII (A) and PvuII (B) digests of PCR products obtained with VT2-e and VT2-f primers. Lanes: M, 100-bp Plus marker; 1, O91:H2
(ovine); 2, O123:H2 (ovine); 3, O128:H2 (ovine); 4, O75:H8 (ovine); 5, O5:H2 (ovine); 6, O91:H2 (human); 7, O123:H2 (human); 8, O128:H2
(human); 9, O5:H2 (human); 10, OX3:H8 (human); 11, O91:H10 (human); 12, O91:H21 (human); 13, O121:H19 (human); 14, O145:H2 (human);
15, O8:H14 (human).
FIG. 2. HincII (A) and AccI (B) digests of PCR products obtained with LinF and LinR primers. Lanes: M, 100-bp Plus marker; uc, undigested
PCR product; 1, O121:H19 (human); 2, O15:H2 (human); 3, O145:H2 (human); 4, O7:H2 (human); 5, O145:H2 (human); 6, O26:H2 (human);
7, O121:H19 (human); 8, O26:H2 (human); 9, O8:H14 (human); 10, O26:H11 (negative control: human isolate with stx1 only); 11, O111:H8
(positive stx2 control; human isolate with both stx1 and stx2); 12, O91:H
2 (ovine); 13, O5:H2 (ovine).
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tain serotypes of STEC seem to be associated with their animal
host species (4, 6a, 20). Studies in our laboratories demon-
strate that STEC isolates recovered from ovine sources possess
serotypes rarely observed among STEC isolates recovered
from bovine sources (Hornitzky et al., unpublished results).
Furthermore, we very rarely observe stx2d subtypes among
STEC isolates recovered from bovine sources in Australia
(Brett et al., unpublished results). Collectively, these results
are consistent with the observation that different stx2 subtypes
associate with certain serotypes and these data have significant
ramifications in epidemiological studies of STEC infections.
These observations also suggest that lamboid phages carrying
different stx2 subtypes lysogenize distinct E. coli populations,
which may be determined by their serotype.
Vero cell assays of ovine isolates possessing stx2d subtypes
are generally toxigenic, with titers down to 1027 (6a). We did
not determine the contribution of Stx1 toxin (which is present
in almost all sheep isolates used in this study) to Vero cell
toxicity. However, Paton et al. (24, 25) reported a low cytoxicity
to Vero cells for the two stx2d variants (stx2d-O111 and stx2d-
OX3a), as did Pierard et al. (26) for the single isolate tested in
that study. Pierard et al. (26) suggested that Stx2d-producing
strains may be a marker for less-pathogenic STEC, since they
often failed to possess associated virulence factors. We did not
observe the eaeA gene among any of the ovine STEC isolates
that possessed stx2d in this study. This result is consistent with
the observations of Pierard et al. (26), who failed to observe
eaeA among 65 isolates displaying stx2d variant genes. How-
ever, in contrast to the findings of Pierard et al. (26), 141 of 146
isolates recovered from ovine sources possessed the ehxA gene.
These data suggest that further studies need to be carried out
to determine the pathogenicity of ovine STEC to humans.
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